Cura Therapeutics
Pre-clinicalCURA Therapeutics is developing the next generation of best/first-in-class multimodal immunotherapies to treat metastatic cancers, pathogen infections, fibrotic diseases, and senescence (longevity).
Founded
2018
Focus
Biologics
About
CURA Therapeutics is developing the next generation of best/first-in-class multimodal immunotherapies to treat metastatic cancers, pathogen infections, fibrotic diseases, and senescence (longevity).
Funding History
1Total raised: $3.2M
Seed$3.2MUndisclosedSep 15, 2021
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile